Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Genome-Wide Association Study-Driven Gene-Set Analyses, Genetic, and Functional Follow-Up Suggest GLIS1 as a Susceptibility Gene for Mitral Valve Prolapse.

Yu M, Georges A, Tucker NR, Kyryachenko S, Toomer K, Schott JJ, Delling FN, Fernandez-Friera L, Solis J, Ellinor PT, Levine RA, Slaugenhaupt SA, Hagège AA, Dina C, Jeunemaitre X, Milan DJ, Norris RA, Bouatia-Naji N.

Circ Genom Precis Med. 2019 May;12(5):e002497. doi: 10.1161/CIRCGEN.119.002497.

PMID:
31112420
2.

Does the Flow Know? Mitral Regurgitant Jet Direction and Need for Valve Repair in Hypertrophic Obstructive Cardiomyopathy.

Schwammenthal E, Hagège AA, Levine RA.

J Am Soc Echocardiogr. 2019 Mar;32(3):341-343. doi: 10.1016/j.echo.2019.01.005. No abstract available.

PMID:
30827370
3.

Long-Term Engraftment (16 Years) of Myoblasts in a Human Infarcted Heart.

Crahès M, Bories MC, Vilquin JT, Marolleau JP, Desnos M, Larghero J, Soulat G, Bruneval P, Hagège AA, Menasché P.

Stem Cells Transl Med. 2018 Oct;7(10):705-708. doi: 10.1002/sctm.18-0017. Epub 2018 Sep 13.

4.

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

Bartko PE, Dal-Bianco JP, Guerrero JL, Beaudoin J, Szymanski C, Kim DH, Seybolt MM, Handschumacher MD, Sullivan S, Garcia ML, Titus JS, Wylie-Sears J, Irvin WS, Messas E, Hagège AA, Carpentier A, Aikawa E, Bischoff J, Levine RA; Leducq Transatlantic Mitral Network.

J Am Coll Cardiol. 2017 Sep 5;70(10):1232-1244. doi: 10.1016/j.jacc.2017.07.734.

5.

GLA-Ring Opportunities and Challenges for Fabry Disease.

Judge DP, Okwuosa IS, Hagège AA.

J Am Coll Cardiol. 2016 Dec 13;68(23):2564-2566. doi: 10.1016/j.jacc.2016.09.952. No abstract available.

6.

Geographic variations in the PARADIGM-HF heart failure trial.

Kristensen SL, Martinez F, Jhund PS, Arango JL, Bĕlohlávek J, Boytsov S, Cabrera W, Gomez E, Hagège AA, Huang J, Kiatchoosakun S, Kim KS, Mendoza I, Senni M, Squire IB, Vinereanu D, Wong RC, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJ.

Eur Heart J. 2016 Nov 1;37(41):3167-3174. Epub 2016 Jun 28.

7.

Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities.

Judge DP, Neamatalla H, Norris RA, Levine RA, Butcher JT, Vignier N, Kang KH, Nguyen Q, Bruneval P, Perier MC, Messas E, Jeunemaitre X, de Vlaming A, Markwald R, Carrier L, Hagège AA.

J Cardiovasc Dev Dis. 2015;2(2):48-65. Epub 2015 Apr 21.

8.

Myocardial Infarction Alters Adaptation of the Tethered Mitral Valve.

Dal-Bianco JP, Aikawa E, Bischoff J, Guerrero JL, Hjortnaes J, Beaudoin J, Szymanski C, Bartko PE, Seybolt MM, Handschumacher MD, Sullivan S, Garcia ML, Mauskapf A, Titus JS, Wylie-Sears J, Irvin WS, Chaput M, Messas E, Hagège AA, Carpentier A, Levine RA; Leducq Transatlantic Mitral Network.

J Am Coll Cardiol. 2016 Jan 26;67(3):275-87. doi: 10.1016/j.jacc.2015.10.092.

9.

Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness.

Damy T, Costes B, Hagège AA, Donal E, Eicher JC, Slama M, Guellich A, Rappeneau S, Gueffet JP, Logeart D, Planté-Bordeneuve V, Bouvaist H, Huttin O, Mulak G, Dubois-Randé JL, Goossens M, Canoui-Poitrine F, Buxbaum JN.

Eur Heart J. 2016 Jun 14;37(23):1826-34. doi: 10.1093/eurheartj/ehv583. Epub 2015 Nov 3.

PMID:
26537620
10.

Mitral valve disease--morphology and mechanisms.

Levine RA, Hagége AA, Judge DP, Padala M, Dal-Bianco JP, Aikawa E, Beaudoin J, Bischoff J, Bouatia-Naji N, Bruneval P, Butcher JT, Carpentier A, Chaput M, Chester AH, Clusel C, Delling FN, Dietz HC, Dina C, Durst R, Fernandez-Friera L, Handschumacher MD, Jensen MO, Jeunemaitre XP, Le Marec H, Le Tourneau T, Markwald RR, Mérot J, Messas E, Milan DP, Neri T, Norris RA, Peal D, Perrocheau M, Probst V, Pucéat M, Rosenthal N, Solis J, Schott JJ, Schwammenthal E, Slaugenhaupt SA, Song JK, Yacoub MH; Leducq Mitral Transatlantic Network.

Nat Rev Cardiol. 2015 Dec;12(12):689-710. doi: 10.1038/nrcardio.2015.161. Epub 2015 Oct 20. Review.

11.

Genetic association analyses highlight biological pathways underlying mitral valve prolapse.

Dina C, Bouatia-Naji N, Tucker N, Delling FN, Toomer K, Durst R, Perrocheau M, Fernandez-Friera L, Solis J; PROMESA investigators, Le Tourneau T, Chen MH, Probst V, Bosse Y, Pibarot P, Zelenika D, Lathrop M, Hercberg S, Roussel R, Benjamin EJ, Bonnet F, Lo SH, Dolmatova E, Simonet F, Lecointe S, Kyndt F, Redon R, Le Marec H, Froguel P, Ellinor PT, Vasan RS, Bruneval P, Markwald RR, Norris RA, Milan DJ, Slaugenhaupt SA, Levine RA, Schott JJ, Hagege AA; MVP-France, Jeunemaitre X; Leducq Transatlantic MITRAL Network.

Nat Genet. 2015 Oct;47(10):1206-11. doi: 10.1038/ng.3383. Epub 2015 Aug 24.

12.

X-chromosome inactivation in female patients with Fabry disease.

Echevarria L, Benistan K, Toussaint A, Dubourg O, Hagege AA, Eladari D, Jabbour F, Beldjord C, De Mazancourt P, Germain DP.

Clin Genet. 2016 Jan;89(1):44-54. doi: 10.1111/cge.12613. Epub 2015 Jun 22.

PMID:
25974833
13.

Dynamic changes of the mitral valve annulus: new look at mitral valve diseases.

Hagège AA, Carpentier A, Levine RA.

Circ Cardiovasc Imaging. 2015 May;8(5). pii: e003539. doi: 10.1161/CIRCIMAGING.115.003539. No abstract available.

14.

Population movement and sudden cardiac arrest location.

Marijon E, Bougouin W, Tafflet M, Karam N, Jost D, Lamhaut L, Beganton F, Pelloux P, Degrange H, Béal G, Tourtier JP, Hagège AA, Le Heuzey JY, Desnos M, Dumas F, Spaulding C, Celermajer DS, Cariou A, Jouven X.

Circulation. 2015 May 5;131(18):1546-54. doi: 10.1161/CIRCULATIONAHA.114.010498. Epub 2015 Mar 11.

PMID:
25762061
15.

Adult patients with Fabry disease: what does the cardiologist need to know?

Hagège AA, Germain DP.

Heart. 2015 Jun;101(12):916-8. doi: 10.1136/heartjnl-2015-307472. Epub 2015 Mar 11. No abstract available.

PMID:
25761995
16.

Pocket-sized focused cardiac ultrasound: strengths and limitations.

Mirabel M, Celermajer D, Beraud AS, Jouven X, Marijon E, Hagège AA.

Arch Cardiovasc Dis. 2015 Mar;108(3):197-205. doi: 10.1016/j.acvd.2015.01.002. Epub 2015 Mar 5. Review.

17.

Screening for rheumatic heart disease: evaluation of a focused cardiac ultrasound approach.

Mirabel M, Bacquelin R, Tafflet M, Robillard C, Huon B, Corsenac P, de Frémicourt I, Narayanan K, Meunier JM, Noël B, Hagège AA, Rouchon B, Jouven X, Marijon E.

Circ Cardiovasc Imaging. 2015 Jan;8(1). pii: e002324. doi: 10.1161/CIRCIMAGING.114.002324.

PMID:
25567654
18.

[2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].

Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw rozpoznawania i postepowania w kardiomiopatii przerostowej, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H.

Kardiol Pol. 2014;72(11):1054-126. doi: 10.5603/KP.2014.0212. Polish. No abstract available.

19.

A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure.

McMurray J, Packer M, Desai A, Gong J, Greenlaw N, Lefkowitz M, Rizkala A, Shi V, Rouleau J, Solomon S, Swedberg K, Zile MR, Andersen K, Arango JL, Arnold M, Bĕlohlávek J, Böhm M, Boytsov S, Burgess L, Cabrera W, Chen CH, Erglis A, Fu M, Gomez E, Gonzalez A, Hagege AA, Katova T, Kiatchoosakun S, Kim KS, Bayram E, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires F, Refsgaard J, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire I, Starling RC, Vinereanu D, Teerlink JR, Wong R; PARADIGM-HF Committees and Investigators.

Eur Heart J. 2015 Feb 14;36(7):434-9.

20.

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.

Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC; PARADIGM-HF Investigators and Coordinators.

Circulation. 2015 Jan 6;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748. Epub 2014 Nov 17.

PMID:
25403646
21.

Cardiogenic shock, asthma, and hypereosinophilia.

Bouabdallaoui N, Arlet JB, Hagege AA.

Am J Emerg Med. 2015 Feb;33(2):309.e1-2. doi: 10.1016/j.ajem.2014.08.019. Epub 2014 Aug 8.

PMID:
25195047
22.

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H.

Eur Heart J. 2014 Oct 14;35(39):2733-79. doi: 10.1093/eurheartj/ehu284. Epub 2014 Aug 29. No abstract available.

PMID:
25173338
23.

The strengths and limitations of the health care system in France.

Hagège AA.

Eur Heart J. 2013 May;34(19):1389-90. No abstract available.

PMID:
23814875
24.

Efficacy of epicardially delivered adipose stroma cell sheets in dilated cardiomyopathy.

Hamdi H, Boitard SE, Planat-Benard V, Pouly J, Neamatalla H, Joanne P, Perier MC, Bellamy V, Casteilla L, Li Z, Hagège AA, Mericskay M, Menasché P, Agbulut O.

Cardiovasc Res. 2013 Sep 1;99(4):640-7. doi: 10.1093/cvr/cvt149. Epub 2013 Jun 13.

PMID:
23771945
25.

An egg-shaped cyst of the right interventricular septum.

Karam N, Azarine A, Menasché P, Hagège AA.

Circulation. 2013 Jun 11;127(23):2351-2. doi: 10.1161/CIRCULATIONAHA.113.001630. No abstract available.

PMID:
23753846
26.

The unsaddled annulus: biomechanical culprit in mitral valve prolapse?

Jensen MO, Hagège AA, Otsuji Y, Levine RA; Leducq Transatlantic MITRAL Network.

Circulation. 2013 Feb 19;127(7):766-8. doi: 10.1161/CIRCULATIONAHA.112.000628. No abstract available.

27.

Comprehensive annular and subvalvular repair of chronic ischemic mitral regurgitation improves long-term results with the least ventricular remodeling.

Szymanski C, Bel A, Cohen I, Touchot B, Handschumacher MD, Desnos M, Carpentier A, Menasché P, Hagège AA, Levine RA, Messas E; Leducq Foundation MITRAL Transatlantic Network.

Circulation. 2012 Dec 4;126(23):2720-7. doi: 10.1161/CIRCULATIONAHA.111.033472. Epub 2012 Nov 8.

28.

Long-term functional benefits of epicardial patches as cell carriers.

Hamdi H, Planat-Benard V, Bel A, Neamatalla H, Saccenti L, Calderon D, Bellamy V, Bon M, Perrier MC, Mandet C, Bruneval P, Casteilla L, Hagège AA, Pucéat M, Agbulut O, Menasché P.

Cell Transplant. 2014 Jan;23(1):87-96. doi: 10.3727/096368912X658836. Epub 2012 Nov 1.

PMID:
23127387
29.

Mapping myocardial fiber orientation using echocardiography-based shear wave imaging.

Lee WN, Pernot M, Couade M, Messas E, Bruneval P, Bel A, Hagège AA, Fink M, Tanter M.

IEEE Trans Med Imaging. 2012 Mar;31(3):554-62. doi: 10.1109/TMI.2011.2172690. Epub 2011 Oct 19.

PMID:
22020673
30.

Consequences of mitral valve prolapse on chordal tension: ex vivo and in vivo studies in large animal models.

Granier M, Jensen MO, Honge JL, Bel A, Menasché P, Nielsen SL, Carpentier A, Levine RA, Hagège AA.

J Thorac Cardiovasc Surg. 2011 Dec;142(6):1585-7. doi: 10.1016/j.jtcvs.2011.08.035. Epub 2011 Sep 28. No abstract available.

31.

The mitral valve in hypertrophic cardiomyopathy: old versus new concepts.

Hagège AA, Bruneval P, Levine RA, Desnos M, Neamatalla H, Judge DP.

J Cardiovasc Transl Res. 2011 Dec;4(6):757-66. doi: 10.1007/s12265-011-9319-6. Epub 2011 Sep 10. Review.

PMID:
21909825
32.

Translational research on the mitral valve: from developmental mechanisms to new therapies.

Judge DP, Markwald RR, Hagège AA, Levine RA.

J Cardiovasc Transl Res. 2011 Dec;4(6):699-701. doi: 10.1007/s12265-011-9320-0. Epub 2011 Sep 7. No abstract available.

33.

Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections.

Hamdi H, Planat-Benard V, Bel A, Puymirat E, Geha R, Pidial L, Nematalla H, Bellamy V, Bouaziz P, Peyrard S, Casteilla L, Bruneval P, Hagège AA, Agbulut O, Menasché P.

Cardiovasc Res. 2011 Aug 1;91(3):483-91. doi: 10.1093/cvr/cvr099. Epub 2011 May 12.

PMID:
21565832
34.

Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study.

Hagège AA, Caudron E, Damy T, Roudaut R, Millaire A, Etchecopar-Chevreuil C, Tran TC, Jabbour F, Boucly C, Prognon P, Charron P, Germain DP; FOCUS study investigators.

Heart. 2011 Jan;97(2):131-6. doi: 10.1136/hrt.2010.200188. Epub 2010 Nov 9.

PMID:
21062768
35.

Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells.

Bel A, Planat-Bernard V, Saito A, Bonnevie L, Bellamy V, Sabbah L, Bellabas L, Brinon B, Vanneaux V, Pradeau P, Peyrard S, Larghero J, Pouly J, Binder P, Garcia S, Shimizu T, Sawa Y, Okano T, Bruneval P, Desnos M, Hagège AA, Casteilla L, Pucéat M, Menasché P.

Circulation. 2010 Sep 14;122(11 Suppl):S118-23. doi: 10.1161/CIRCULATIONAHA.109.927293.

PMID:
20837902
36.

Relief of mitral leaflet tethering following chronic myocardial infarction by chordal cutting diminishes left ventricular remodeling.

Messas E, Bel A, Szymanski C, Cohen I, Touchot B, Handschumacher MD, Desnos M, Carpentier A, Menasché P, Hagège AA, Levine RA.

Circ Cardiovasc Imaging. 2010 Nov;3(6):679-86. doi: 10.1161/CIRCIMAGING.109.931840. Epub 2010 Sep 8.

37.

First evaluation using a validated scale of the risk of congestive heart failure among hypertensive patients treated by general practitioners (O-PREDICT survey).

Hagège AA, Demil N, Errieau G, Aupetit JF, Dievart F, Mourad JJ.

Arch Cardiovasc Dis. 2010 Mar;103(3):176-83. doi: 10.1016/j.acvd.2010.01.001. Epub 2010 Mar 11.

38.

Letter by Messas et al regarding article, "Initial results of posterior leaflet extension for severe type IIIb ischemic mitral regurgitation".

Messas E, Hagège AA, Emmerich J.

Circulation. 2010 Feb 16;121(6):e36. doi: 10.1161/CIR.0b013e3181d22cd4. No abstract available.

PMID:
20159839
39.

New trends in treatment of hypertrophic cardiomyopathy.

Hagège AA, Desnos M.

Arch Cardiovasc Dis. 2009 May;102(5):441-7. doi: 10.1016/j.acvd.2009.03.008. Epub 2009 May 12. Review.

40.

[Management of the patient with chronic coronary artery disease].

Hagège AA.

Rev Prat. 2008 Sep 30;58(14):1541-8. French.

PMID:
18839682
41.

Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium.

Perez-Ilzarbe M, Agbulut O, Pelacho B, Ciorba C, San Jose-Eneriz E, Desnos M, Hagège AA, Aranda P, Andreu EJ, Menasché P, Prósper F.

Eur J Heart Fail. 2008 Nov;10(11):1065-72. doi: 10.1016/j.ejheart.2008.08.002. Epub 2008 Sep 20.

42.

Self-assembling peptide nanofibers and skeletal myoblast transplantation in infarcted myocardium.

Dubois G, Segers VF, Bellamy V, Sabbah L, Peyrard S, Bruneval P, Hagège AA, Lee RT, Menasché P.

J Biomed Mater Res B Appl Biomater. 2008 Oct;87(1):222-8. doi: 10.1002/jbm.b.31099.

PMID:
18386833
43.

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagège AA.

Circulation. 2008 Mar 4;117(9):1189-200. doi: 10.1161/CIRCULATIONAHA.107.734103. Epub 2008 Feb 19.

PMID:
18285565
44.

Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium?

Chanséaume S, Azarnoush K, Maurel A, Bellamy V, Peyrard S, Bruneval P, Hagège AA, Menasché P.

Interact Cardiovasc Thorac Surg. 2007 Jun;6(3):293-7. Epub 2007 Mar 26.

PMID:
17669846
45.

[Inherited metabolic cardiomyopathies].

Germain DP, Linhart A, Desnos M, Hagège AA.

Presse Med. 2007 Mar;36 Spec No 1:1S48-54. Review. French.

PMID:
17546768
46.

Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats.

Tomescot A, Leschik J, Bellamy V, Dubois G, Messas E, Bruneval P, Desnos M, Hagège AA, Amit M, Itskovitz J, Menasché P, Pucéat M.

Stem Cells. 2007 Sep;25(9):2200-5. Epub 2007 May 31.

47.

Is xenotransplantation of embryonic stem cells a realistic option?

Bonnevie L, Bel A, Sabbah L, Al Attar N, Pradeau P, Weill B, Le Deist F, Bellamy V, Peyrard S, Ménard C, Desnos M, Bruneval P, Binder P, Hagège AA, Pucéat M, Menasché P.

Transplantation. 2007 Feb 15;83(3):333-5.

PMID:
17297408
48.

Can bone marrow-derived multipotent adult progenitor cells regenerate infarcted myocardium?

Agbulut O, Mazo M, Bressolle C, Gutierrez M, Azarnoush K, Sabbah L, Niederlander N, Abizanda G, Andreu EJ, Pelacho B, Gavira JJ, Perez-Ilzarbe M, Peyrard S, Bruneval P, Samuel JL, Soriano-Navarro M, García-Verdugo JM, Hagège AA, Prósper F, Menasché P.

Cardiovasc Res. 2006 Oct 1;72(1):175-83. Epub 2006 Jul 21.

PMID:
16934240
49.

Chordal cutting does not adversely affect left ventricle contractile function.

Messas E, Yosefy C, Chaput M, Guerrero JL, Sullivan S, Menasché P, Carpentier A, Desnos M, Hagege AA, Vlahakes GJ, Levine RA.

Circulation. 2006 Jul 4;114(1 Suppl):I524-8.

PMID:
16820631
50.

Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients.

Hagège AA, Marolleau JP, Vilquin JT, Alhéritière A, Peyrard S, Duboc D, Abergel E, Messas E, Mousseaux E, Schwartz K, Desnos M, Menasché P.

Circulation. 2006 Jul 4;114(1 Suppl):I108-13.

PMID:
16820558

Supplemental Content

Loading ...
Support Center